Company Profile
EKF Diagnostics provides the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and globally.
The company offers DiaSpect Tm analyzer. Its portfolio also includes Hemo Control, a hemoglobin analyzer, and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples Glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Clinic.
Its portfolio also includes Quo-Lab HbA1c, a desktop point-of-care analyzer for measuring glycated hemoglobin, Quo-Test HbA1c, fully automated hemoglobin A1c analyzer for the monitoring and management of diabetes, and STAT-Site W Beta-Hydroxybutyrate analyzer. Additionally, it offers Creamatocrit Plus, a breast milk analyzer.
Its portfolio also includes QuPID and True20 pregnancy tests, Lactate Scout Vet, a handheld lactate analyzer for veterinary care, Hemo Vet, a point-of-care hemoglobin and hematocrit analyzer, Lactate Scout Sport, a lactate analyzer for sports performance, Biosen series for sports, and EKF Link, a data management solution that integrates point-of-care analyzers
Beta-Hydroxybutyrate LiquiColor for monitoring ketosis. Its portfolio also includes RaPET, a range of immunoassay kits, QuStick Strep A for Strep A infection treatment, Hema-Screen Lab Pack for detection of colorectal cancer, PrimeStore MTM, a molecular transport medium that preserves and stabilizes DNA and RNA, Uri-Trak 120M urine analyzer, and clinical chemistry reagents, controls, and standards.
Additionally, it provides precision fermentation, custom bioprocessing, and contract manufacturing solutions Diagnostic enzymes that include arylacylamidase, beta-hydroxybutyrate dehydrogenase, and salicylate hydroxylase. Founded in 1990, the company is headquartered in Cardiff, the United Kingdom.